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∇Department of Sensors and Detectors, Institute of Electrical Engineering, Slovak Academy of Sciences, Dubravska cesta 9, Bratislava,
841 04, Slovak Republic
*S Supporting Information
ABSTRACT: Impedimetric lectin biosensors capable of recognizing two
different carbohydrates (galactose and sialic acid) in glycans attached to
antibodies isolated from human serum were prepared. The first step entailed
the modification of a gold surface by a self-assembled monolayer (SAM)
deposited from a solution containing a carboxybetaine-terminated thiol
applied to the subsequent covalent immobilization of lectins and to resist
nonspecific protein adsorption. In the next step, Sambucus nigra agglutinin
(SNA) or Ricinus communis agglutinin (RCA) was covalently attached to the
SAM, and the whole process of building a bioreceptive layer was optimized
and characterized using a diverse range of techniques including electro-
chemical impedance spectroscopy, cyclic voltammetry, quartz crystal micro-
balance, contact angle measurements, zeta-potential assays, X-ray photo-
electron spectroscopy, and atomic force microscopy. In addition, the
application of the SNA-based lectin biosensor in the glycoprofiling of
antibodies isolated from the human sera of healthy individuals and of patients suffering from rheumatoid arthritis (RA) was
successfully validated using an SNA-based lectin microarray. The results showed that the SNA lectin, in particular, is capable of
discriminating between the antibodies isolated from healthy individuals and those from RA patients based on changes in the
amount of sialic acid present in the antibodies. In addition, the results obtained by the application of RCA and SNA biosensors
indicate that the abundance of galactose and sialic acid in antibodies isolated from healthy individuals is age-related.
1. INTRODUCTION
Glycosylation is the most common co- and post-translational
modification of proteins; it may be estimated that approximately
70% of cytosolic and 80% of membrane-bound human proteins
are glycosylated.1,2 Glycans play an important role in many
different processes (e.g., viral infection, cancer development, cell-
signaling and adhesion, proper functioning of an immune
system), as they enhance the solubility and stability of many
proteins but may also determine the function of proteins.3−10
The presence/absence of a single carbohydrate within a glycan
structure can significantly influence the function of proteins. The
addition of a single molecule of sialic acid (N-acetylneuraminic
acid) to the glycan present in the Fc fragment of immunoglobulin
(IgG), thereby changing the protein from being a pro-
inflammatory to an anti-inflammatory agent, can serve as a
good example.11,12 Although over 70% of all therapeutic proteins
are glycoproteins,13 the first glyco-engineered therapeutic
antibody was only launched as recently as in 2012;14 today
significant focus is directed toward controlling the glycosylation
of therapeutics.15
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Changes in the glycan structure in selected glycoprotein
biomarkers are often the result of a disease progression,8,16,17 but
may also be associated with aging.18 In the case of autoimmune
diseases (e.g., rheumatoid arthritis, RA),19,20 where the antibod-
ies present in human plasma are produced against the host’s own
tissues, their glycan composition is changed.21 Detailed analysis
of glycans is only made possible by using a battery of
instruments,16 but lectins (natural glycan decipherers) interact-
ing with glycans attached to intact proteins can provide
functional information about glycans.22 Lectins are (glyco)-
proteins selectively binding some glycan residues or simple
mono- or oligosaccharide structures present in more complex
glycans. These molecules are potentially more useful in the
search for new biomarkers in complex biological samples than
the standard immunochemical protocols because, in lectin-based
applications, prior knowledge of a biomarker’s identity or its
structure is not required. For glycocode-deciphering, lectins are
often applied as an effective tool in many clinical diagnostic
procedures, mostly in the microarray analysis, affording an
extremely high throughput, simplicity, and reproducibility of
assays.23−26
Faradaic electrochemical impedance spectroscopy (EIS) is a
powerful tool in bioanalysis, because it enables the determination
of analytes down to the aM concentration range.8 The method is
based on a small sinusoidal perturbation of a thin conductive or
semiconductive surface layer using a low amplitude voltage; for a
spectrum of different frequencies, it provides information about
surface capacitance, solution, and charge-transfer resistance.27
Moreover, it represents a label-free detection method, hence
reducing the negative effect of labeling on a biorecognition event
and lectin structure.8,28 It has been successfully used for the
detection of a variety of molecules, viruses, or even whole
bacterial or eukaryotic cells in different configurations.8,29 Most
recently, some new variations of this method have been
presented, that is, impedance-derived electrochemical capaci-
tance spectroscopy for the evaluation of lectin-glycoprotein
binding affinity30 and immittance electroanalysis.31
It is of the utmost importance to control nonspecific protein-
binding, especially when using biosensor devices based on label-
free detection platforms.32−34 While molecules bearing oligo-
ethylene glycol (OEG) moieties have been successfully applied
to resist nonspecific protein binding in the past, zwitterionic
molecules that bind water molecules more strongly than OEG-
based molecules, thus exhibiting greater repulsive force against
protein adsorption, are becoming more widely used.32,35 Oligo-
and poly-zwitterionic molecules attached to various interfaces
can be used in a number of applications.36 In addition to the
ability to resist nonspecific protein binding,34,37 zwitterionic
polymers can provide nonbiofouling surfaces (resisting microbial
adhesion),38,39 exhibiting bactericidal effects38,39 beneficial for
wound-healing or the prolonged blood circulation of polymer-
modified particles.40 Poly- and oligo-zwitterionic molecules are
not ideal for the construction of impedimetric biosensors,
because the interfacial layer of such devices has to be built up so
as to produce amoderate initial charge-transfer resistance (RCT≈
tens of kΩ).22 Hence, in a previous study, thiolated
sulphobetaine (SB) with only one zwitterionic unit was applied
to the construction of an EIS lectin-based biosensor with the
subsequent glycoprofiling of serum samples.41 Resistance to the
adsorption of nonspecific proteins was guaranteed by the
formation of a mixed SAM composed of 11-mercaptoundecanoic
acid (MUA, for covalent lectin immobilization) and SB (resisting
nonspecific interactions and being a MUA diluent).41 The
problematic mixing of these two thiols (SB dissolved in water and
MUA in ethanol) resulted in the preparation of interfacial layers,
which affected the performance of such a device.41 The present
study’s first aim was to increase the reproducibility of the
biosensor preparation by the application of a carboxybetaine-
containing thiol (CB, applicable for covalent lectin immobiliza-
tion and resisting nonspecific protein binding) to form a one-
component SAM with high reproducibility. The second aim was
to separate antibodies (i.e., IgG’s, Figure 1) from human serum
from healthy individuals and RA patients to increase the
sensitivity of glycoprofiling. It should be noted that a short
aliphatic thiol bearing a carboxybetaine moiety was recently
applied to gold patterning together with a boronate-containing
thiol recognizing fructose for the label-free detection of this
analyte.42
2. MATERIALS AND METHODS
2.1. Chemicals. Potassium hexacyanoferrate(III) (ferricyanide),
potassium hexacyanoferrate(II) trihydrate (ferrocyanide), potassium
chloride, phosphate buffer saline tablets, sulfuric acid, sodium hydroxide,
N-hydroxysuccinimide (NHS), N-(3-(dimethylamino)propyl)-N′-eth-
ylcarbodiimide hydrochloride (EDC), Ricinus communis agglutinin
(RCA, recognizing galactose, caution: handle with special care because
it is a biological toxin), fetuin (FET, contains 8.7% of sialic acid), and
asialofetuin (ASF, contains ≤0.5% of sialic acid) were purchased from
Sigma-Aldrich (U.S.). Sambucus nigra agglutinin type I (SNA,
Figure 1. Structure of human immunoglobulin G (IgG) (pdb code 1MCO) with (a) visible glycan moieties in the cavity created by two heavy chains in
Fc fragment and (b) lateral view of the same molecule showing availability of two glycan chains for lectin biorecognition (red arrows).
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recognizing sialic acid) lectin from Sambucus nigra was purchased from
EYLabs (U.S.). Ethanol for UV/vis spectroscopy (ultrapure) was
purchased from Slavus (Slovakia). Biotinylated lectins and a carbo-free
blocking solution were purchased from Vector Laboratories (U.S.).
CF555-streptavidin fluorescent label was purchased from Biotium
(U.S.). All solutions were filtered prior to use (using 0.2 μm sterile
filters) and prepared in ultrapure distilled water (DW). The synthesis of
the carboxybetaine thiol (CB) together with its spectral analysis is
provided in the Supporting Information, and the key steps in the
synthesis are shown in Scheme 1.
2.2. Human Serum Samples. Three (N = 3) serum samples from
female patients with seropositive RA (#6, #11, #62, mean age = 72.0 yrs)
were used. All RA patients had a severe form of RA (stage III) and were
on treatment with methotrexate. One RA patient was treated with
nonsteroidal anti-inflammatory drugs. All RA patients met the 2010
ACR-EULAR classification criteria for RA.43 The RA patients were
recruited from the National Institute for Rheumatic Diseases in
Piesť’any, Slovakia. Six (N = 6) control serum samples from females
were included in the study (younger (#34, #37, #64, mean age = 30.0
yrs) and older healthy individuals (#28, #41, #82, mean age = 67.3 yrs)).
The control subjects were recruited from the laboratory staff of the
Institute of Experimental Endocrinology, Slovak Academy of Sciences,
Bratislava, Slovakia. All subjects gave their informed written consent,
and the study was approved by the Ethics Committee of the National
Institute for Rheumatic Diseases, Piesť’any, Slovakia, in accordance with
the ethical guidelines of the Helsinki Declaration as revised in 2000. The
blood samples were collected into polyethylene tubes with a clotting
activator (S-Monovette, Sarstedt AG & Co., Nümbrecht, Germany).
After centrifugation, the serum aliquots were stored at−20 °C until they
were analyzed.
2.3. Gold Chip Preparation. Thin films of titanium (purity
99.995%, thickness ∼5 nm) and gold (purity 99.995%, ∼100 nm) were
evaporated in an ultrahigh vacuum PVD apparatus on an oxidized silicon
wafer 76 mm in diameter. The thin Ti sublayer was used for enhancing
the adhesion of the Au layer. Next, the wafer was cut into chips 10 × 10
mm2 using a diamond saw (MicroAce 3AV+, Loadpoint; UK)
commonly used in the microelectronics industry.
2.4. Electrode Pretreatment and SAM Layer Formation. The
polycrystalline gold electrodes (BASi, U.S., d = 1.6 mm) were treated as
previously described using electrochemical reductive desorption,
mechanical polishing, chemical treatment, and a repeated electro-
chemical polishing and stripping procedure.44 In summary, in the first
step the previously bound thiol molecules were desorbed from the
surface using cyclic voltammetry (CV) in 100 mM NaOH under
anaerobic conditions (100 scans from −500 to −1500 mV at a scan rate
of 100 mV s−1), and then the electrodes were polished mechanically
using a polishing pad and alumina slurry (particle size 1 and 0.3 μm, each
for 5 min) and left after short sonication in a hot piranha solution for 20
min (H2O2 and H2SO4 at 1:3 ratio, caution: handle with special care).
Next, CV was performed again in 100 mMH2SO4 (25 scans from −200
to +1500 mV at a scan rate of 100 mV s−1) for the electrochemical
polishing and gold oxide stripping (10 scans, from +750 to +200 mV at a
scan rate of 100 mV s−1), respectively. All steps were performed using a
laboratory potentiostat/galvanostat PGSTAT 128N (Ecochemie, The
Netherlands) in a three-electrode cell system, using auxiliary Pt and
reference Ag/AgCl electrodes. Immediately after the gold oxide
stripping procedure was completed, the electrodes were washed with
DW, left to dry in a dust-free environment, and subsequently used for
formation of the self-assembled monolayer (SAM) of 1 mM thiol stock
solution in DW freshly prepared prior to use.
2.5. Zeta (ζ) Potential Measurements. Square-shaped gold chips
(10 × 10 mm2, provided by the Institute of Electrical Engineering,
Slovak Academy of Sciences; see section 2.3) were modified as
previously described for the planar gold electrodes. The ζ potential of
the modified Au surfaces was determined using a SurPASS Electro-
kinetic Analyzer (Anton Paar GmbH, Austria) with a commercial
adjustable gap cell and with a background KCl electrolyte with a
concentration of 1 mM. A solution of 0.1 M electrolyte solution was
used for correcting the resistance. The flow of electrolyte solution, which
is forced by hydraulic pressure against the electrochemical double layer,
disrupts the distribution of ions in the electrochemical double layer and
generates a potential difference, denoted as the streaming potential. The
ζ potential was obtained from the streaming potential measurements on
the basis of the Helmholtz−Smoluchowski equation as follows:
ζ η
ε ε
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where U is the streaming potential, p is the pressure drop across the
streaming channel, ε0 is the vacuum permittivity, εr is the dielectric
constant of the aqueous solution, η is the electrolyte solution viscosity, L
is the channel length, A is the cross-section area of the streaming
channel, and R is the resistance of the measuring cell. The streaming
pressures in the rinse mode and in the measurement mode were set at 20
and 50 kPa, respectively. The viscosity and permittivity of the electrolyte
were calculated on the basis of the temperature using a calibration curve.
2.6. Electrochemical Impedance Spectroscopy (EIS) Measure-
ments. On an electrode modified by a SAM, the biorecognition
elements (SNA and RCA lectins) were immobilized using standard
amine coupling with carboxylic groups of CB being activated by a 1 + 1
mixture of 0.2 M EDC in DW and 0.05 M NHS in DW for 10 min
(Scheme 2). The lectins were covalently immobilized on the activated
SAM layer from a 40 μL stock solution (1 mg mL−1 in PBS). All
electrochemical impedance spectroscopy (EIS) measurements were
performed in a filtered electrolyte containing 5 mM ferricyanide, 5 mM
ferrocyanide, and 0.1 M KCl. The analysis was conducted at 50 different
frequencies (ranging from 0.1 Hz to 100 kHz) using Nova Software 1.10
(Ecochemie, The Netherlands). The data acquired were evaluated by
the same software using a Nyquist plot with a Randles−Erschler
equivalent circuit R(C[RW]) employed. The change in charge-transfer
resistance (RCT) relative to a reference surface (a biosensor surface after
the lectin immobilization and stabilization in a sterile 100 mM KCl
solution for at least 15 min) expressed in % was used as a measurement
signal. Each analyte/sample was measured in triplicate at least, using an
independent biosensor device, and the results are shown with a standard
deviation (±SD) calculated in Excel. Human samples were diluted in a
sterile and filtered 10 mM PBS buffer, pH 7.4 containing chloride ions
(tablets) to prevent any significant changes in ionic strength during the
experiment. The analysis of each sample lasted for 40 min including
incubation of the sample with the biosensor device for 20 min, and then
the biosensor was incubated for 10 min in a sterile 100 mMKCl solution
Scheme 1. Synthesis of Carboxybetaine-Containing Thiol Derivative 1a
a(i) N,N-Dimethyl glycine ethyl ester, acetone, 3 days, ambient temperature; (ii) CH3CSOH, AIBN, MeOH, UV, ambient temperature; (iii) IRA
400.
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with a subsequent impedimetric analysis conducted for an additional 10
min. All stock solutions (lectins, standard glycoproteins, and human
samples) were stored at −20 °C in aliquots for periods not exceeding 1
month.
2.7. Atomic Force Microscopy (AFM) Measurements. Peak
force tapping mode atomic force microscopy (Scan Asyst, Bruker, U.S.)
in air mode was carried out on a Bioscope Catalyst instrument and
Olympus IX71 microscope in conjunction with NanoScope 8.15
software using ScanAsyst in air mode. Square-shaped gold chips (10 ×
10 mm2, provided by the Institute of Electrical Engineering, Slovak
Academy of Sciences; see section 2.3) modified as previously described
for the planar gold electrodes were scanned using a SCANASYST-AIR
silicon tip on a nitride lever (Bruker, U.S., with f 0 = 50−90 kHz and k =
0.4 N m−1), sharpened to a tip radius of 2 nm.
2.8. Quartz Crystal Microbalance (QCM) Measurements. All
QCM measurements were performed using Autolab PGSTAT 128N
(Ecochemie, The Netherlands) equipment using an EQCM module.
The changes per mass were evaluated using Sauerbrey’s equation:
ρ
Δ = −
μ
·Δf
f
A
m
2 0
2
q q (1)
where Δf is the frequency change (Hz), f 0 is the nominal resonant
frequency of the crystal (6 MHz), Δm is the change in mass (g cm−2)
and μq is the shear modulus of a quartz crystal (g cm
−1 s−2), A is the
surface area, and ρq is the density of quartz in g mL
−1. For a 6 MHz
crystal, the whole equation can be simplified to
Δ = − ·Δf C mf (2)
where Cf is the frequency constant 0.0815 Hz ng
−1 cm−2. The
measurements were monitored and evaluated using Nova 1.10 software,
and all measurements were carried out at ambient temperature.
2.9. Lectin Microarrays (MA). The lectin microarray experiments
were performed with 10 mM phosphate buffer solution (PBS) as a
printing buffer, PBST (phosphate buffer solution with the addition of
0.05% Tween 20) as a washing buffer, and PBST containing 10× diluted
carbo-free blocking solution applied as a blocking buffer. In summary, at
least four different concentrations and five different spots for each
standard glycoprotein (FET, ASF) or 800× diluted human serum
samples, respectively, were spotted using a SpotBot3Microarray Protein
edition (Arrayit, U.S.) on epoxide-coated slides Nexterion E (Schott,
Germany) using a previously optimized protocol.45 The spotting
temperature was set at 10 °C and the humidity up to 60%. Subsequently,
the slide was placed in a humidity chamber for 1 h at ambient
temperature with a humidity of 80−90%, blocked using a blocking buffer
at ambient temperature for 1 h, and with slow shaking, rinsed under a
gentle stream of a printing buffer in a Petri dish, then drained. Next, 80
μL of 25 μg mL−1 biotinylated lectin in a binding buffer was applied to
the slide surface and incubated for 1 h. After the lectin incubation, the
slide was incubated with the Biotium CF555-streptavidin solution (80
μL of 5 μg mL−1 in a printing buffer) for 15 min in the dark. After the
washing procedure (PBS, distilled water), the slide was scanned using an
InnoScan710 scanner (Innopsys, France) at a wavelength of 532 nm.
The slide image was evaluated using Mapix 5.5.0 by evaluating the
intensity of the fluorescence and the intensity of all independent array
spots on the array.
2.10. Isolation of Antibodies from Human Serum. Human IgG
(from real human sera) were isolated using a Melon Gel IgG Spin
Purification Kit (Thermo Scientific, U.S.), affording a reproducible
purification of human samples, comparable to those using protein A or
G. In summary, serum samples were diluted and processed according to
the manufacturer’s protocol. After the procedure, the IgG concen-
trations in the stock solution and in the original sample were determined
byUV spectrophotometry (at 280 nm) and the Lambert−Beer law using
the molar extinction coefficient ε = 210 000 M−1 cm−1 provided by the
manufacturer. The output signals obtained from both of the lectin-based
bioanalytical methods (EIS and MA) were divided by the IgG
concentration in the stock solution.
3. RESULTS AND DISCUSSION
3.1. SAM Layer Formation and Characterization.
Contact Angle Measurements. The bare Au surface (after the
piranha cleaning procedure for a few minutes) exhibited a
moderate level of hydrophobicity/hydrophilicity with a contact
angle of 63.5°, a value comparable to the values of 70°46 and
62°47 obtained in previous studies. After formation of the CB
monolayer on the Au surface, the hydrophilicity of an interface
increased, as can be observed from the contact angle of 40°
obtained on such a modified gold surface. This contact angle
value is in agreement with the value of 34° obtained on a
poly(carboxybetaine methacrylate)-modified surface48 and with-
in the contact angles of 33−53° obtained on various poly-
(carboxybetaine methacrylamide)-modified surfaces.49
AFM Measurements.Monitoring of the differences in surface
topology between the bare Au chips and the same chips modified
with a CB monolayer using AFM exhibited no difference in
surface roughness ((0.37 ± 0.18) nm for bare Au and (0.39 ±
0.12) nm for a CB SAM-modified surface, respectively; p > 0.05
for at least three different samples), suggesting that the topology
of the SAM copied the surface topology of the bare gold surface,
creating a uniform and dense layer.
Zeta (ζ) Potential Measurements. Zeta potential measure-
ments at pH 7 revealed that, upon formation of CB SAM, the
value of the ζ potential of the bare Au surface decreased from
−80 to −120 mV. Note that the zeta potential values are very
dependent on pH value and overall conductivity of the substrate
surface and partially dependent on shape and structure of the
substrate and zeta potential assay method. These values are
comparable to the ζ potential of a similar system where the value
for carboxylic acid-SAM was determined as −100 mV at pH 7.50
Other studies refer to the ζ potential value of (−187± 7) mV for
carboxylic acid-terminated SAMs.51,52 Moreover, mixed pos-
itive/negative charged SAMs have isoelectric point shifted to pH
lower than 7.50 Even zwitterionic SAM on the gold solid surface
might have significantly negative ζ potential value at pH 7.
All of these measurements together with XPS data on SAM
(see Supporting Information) are consistent with the successful
formation of CB SAM on a bare gold surface. Accordingly, the
Scheme 2. Graphical Representation of Biosensor Built Up
with Initial Formation of SAM Layer (Carboxybetaine-
Containing Thiol) on Au Surface, Followed by Activation of
−COOH Groups by a Mixture of EDC and NHS and Finally
by Immobilization of Lectin (Blue)a
aInteraction of analyte (antibody in green) with biosensor is shown,
and repulsion of proteins, which is not an analyte (antibody in red), is
also shown.
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CB-modified gold surface was ready for the subsequent
activation of−COOH groups of CB for covalent immobilization
of two different lectins, RCA and SNA.
3.2. Optimization of Activation Time Using EDC/NHS
Chemistry. Because the CB SAM does not contain any diluting
thiol, the density of the −COOH groups present in the SAM is
too high, and the only way to control the density of the
immobilized lectin is to optimize the time of activation by EDC/
NHS. The optimal time of activation of the −COOH groups by
EDC/NHS was followed by QCM (obtaining surface lectin
density) and AFM (reading surface roughness). The results
obtained from QCM and AFM consistently showed that the
highest lectin density was obtained with an activation time of 10
min (Figure 2).
The lectin surface coverage increased from a value of 4.2 pmol
cm−2 to a value of 6.2 pmol cm−2 when the activation time was
increased from 5 to 10 min. It is worth noting that the lectin
surface coverage decreased to a value of 3.7 pmol cm−2 when the
surface confined −COOH groups were activated for 15 min.
This low lectin surface coverage of 3.7 pmol cm−2 can be
explained by hydrolysis of the activated esters in an aqueous
solution during incubation for 15 min, resulting in a decreased
density of activated esters available for covalent lectin
immobilization. The AFM experiments revealed a similar
pattern, that is, an increased surface roughness Rq from a value
of 0.39 nm (without activation, i.e., CB SAM) to a value of 0.96
nm (5 min activation) and further to a value of 1.4 nm (10 min
activation) (Figure 3). Finally, a decrease to a value of 1.2 was
observed when the surface was activated for 15 min (Figure 3).
On the basis of these results, a 10 min activation time was
selected for the covalent immobilization of lectins in subsequent
experiments.
3.3. EIS Characterization and Measurements. First, the
charge-transfer resistance (RCT) of the prepared surfaces,
corresponding to a diameter in a semicircle region of a Nyquist
plot, was investigated (Figure 4A). The bare Au electrodes
exhibited an average initial RCT value of 87 Ω. However, the RCT
value only shifted slightly to a value of (98 ± 4) Ω after
incubation with a CB solution. After SNA lectin immobilization,
RCT increased to a value of (620± 10)Ω. A sharp increase in RCT
to a value of (2700 ± 640) Ω was observed upon incubation of
the biosensor with IgG analyte (Figures 4A and 5). The cyclic
voltammetry measurements (Figure 4B) are consistent with the
EIS investigation, showing that immobilization of an SNA lectin
on CB SAM-modified gold formed a quite effective barrier,
resulting in a decreased reversibility of the ferricyanide
electrochemistry with ΔEp = 134 mV in comparison with ΔEp
= 94 mV observed on a CB SAM-modified Au surface.
3.4. Calibration of EIS Lectin Biosensor and Analysis of
Real Biological Samples. Calibration of the EIS lectin
biosensor was performed only with the SNA lectin immobilized,
because the limit of detection and working concentration ranges
for the SNA- and RCA-based lectin biosensors were found to be
similar in a previous study.41 ASF containing a much lower
amount of sialic acid than in FET can also be detected, but with a
slightly lower sensitivity ((21.0± 1.5)% for ASF vs (30.8± 1.1)%
for FET). For every calibration curve constructed (in Figure 6),
an average SD was calculated. As noise for the measurement for a
particular analyte, 3× average SD was calculated. In the
subsequent step, the concentration of both analytes (FET and
ASF) for both methods of analysis (EIS and MA) above this
noise level was found, and this value is presented as the limit of
detection (LOD). For EIS measurements, the LOD for FET was
3.5 × 10−6 mg mL−1 (73 pM) and for ASF was 1.3 × 10−6 mg
mL−1 (2.7 nM). For the MA assays, the LOD for FET was 0.015
mg mL−1 (310 nM) and for ASF was 0.020 mg mL−1 (420 nM).
The lectin-based microarray affords an LOD approximately 4
orders of magnitude higher than the EIS lectin-based biosensor
for the main analyte FET (Figure 6). A much lower limit of
detection for EIS than for MA was also observed in the previous
study.41 It is worth noting that the SD in Figure 6 for EIS is not
the SD of the assay but rather the SD of a biosensor preparation,
because every calibration or sample measurement by EIS was
performed with an independently prepared biosensor device.
The LOD of the impedimetric SNA biosensor based on CB is 73
pM, a value much higher than the value of 24 fM (a value
recalculated from ref 41) for the impedimetric SNA biosensor
based on a mixed SAM composed of MUA and SB. This
difference might be the result of a larger initial RCT of the
interface of the SNA biosensor previously published (32 kΩ)41 as
compared to this study (620Ω), indicating that a moderate initial
RCT is essential to obtain a high level of detection for
impedimetric devices, as discussed previously.27 Moreover, the
impedimetric SNA biosensor based on a mixed SAM composed
of MUA and SB was more resistant to nonspecific protein
binding (6.1% of the specific response),41 in comparison with the
30% of nonspecific response (using human serum albumin)
observed for the current SNA biosensor (data not shown). The
beneficial features of the current SNA biosensor over that
previously published based on MUA and SB41 are the higher
reproducibility of the biosensor construction (average RSD of
8.9% vs 16.1%), higher sensitivity of analysis (30.8% M−1 vs
14.6%M−1), and a more reliable calibration curve expressed as R2
(0.993 vs 0.954).41 The increase in initial RCT needed to render
the EIS-based lectin biosensor more sensitive and robust can be
achieved by blocking the biosensor surface with bovine serum
albumin as previously proposed for suspended microchannel
resonators;34 this blocking procedure made the analysis of
analytes in serum reliable.34
Suitable data for comparing the analytical performance of the
proposed impedimetric biosensor with other glycoprofiling
methods are not easy to find, but a lectin-based analogy of
ELISA can offer an LOD down to the pM level with a linear range
(LR) spanning 1 order of concentration magnitude;45,53 the
lowest LOD for EIS-based biosensors is in aM−fM range with
Figure 2. Correlation between surface density of immobilized SNA
lectin (black) and surface roughness of the surface with immobilized
SNA expressed as Rq (red) obtained from QCM and AFM experiments,
respectively. SNA lectin was immobilized from 1 mg mL−1 stock
solution in 10 mM PBS.
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the LR spanning 3−9 orders of magnitude,8,28 and an LOD of 67
nM for SPR and QCM lectin-based methods with LR of 1−2
orders of magnitude was demonstrated.28 Label-based lectin
biosensors offer an LOD down to 3 pM with the LR spanning 3
orders of magnitude.28 The main advantage of lectin-based
glycoprofiling is the ability to analyze even intact cells (i.e.,
cancerous cells) without any treatment.10,37 Instrumental
techniques make it possible to glycoprofile samples down to
Figure 3. 3D AFM images (from top left to bottom right) of CB SAM-modified Au surface after piranha cleaning procedure (0 min activation) and after
SNA lectin immobilization with 5, 10, and 15 min activation times. The range of the z-axis in all AFM images was set at 5 nm to see the differences in the
surface topology clearly.
Figure 4. Nyquist plots (obtained from EIS investigation) of bare gold electrode (black), CB SAM layer deposited on Au surface (blue), and the same
layer after immobilization of SNA lectin (green) (A). Inset in (A) shows Nyquist plots with high magnification zoomed to initial values, and also shows
that RCT value is read as a diameter of a semicircle for a particular Nyquist plot as depicted for bare Au surface (black) and for surface after immobilization
of SNA lectin (green). Corresponding cyclic voltammograms for all interfacial layers are also shown (B). In this experiment, EIS and CV of traditional
SAM layer applied to covalent protein immobilization composed of 11-mercaptoundecanoic acid (MUA, red line with RCT too high to be calculated)
were also characterized.
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the attomolar−femtomolar level with a few microliters of the
sample (∼pM−nM level) with a linear range spanning 2−3
orders of magnitude.16,54,55
Because the second aim of this study was to apply developed
EIS-based lectin biosensors to the glycoprofiling of isolated IgG’s
(antibodies), the analysis of which is more relevant to studying
the progression of the RA disease than glycoprofiling a whole
serum sample, affinity columns were applied to isolate IgG’s
(antibodies) from the serum samples. A simple comparison of
the relative output signal (i.e., ΔRCT divided by the total protein
content) revealed an enhancement of the signal 65.6-fold (slope
of 25.6 ± 1.2 vs 0.39 ± 0.01) (Figure 7), a feature important for
the enhanced reliability of the analysis. In the subsequent
experiment, the nonfouling properties of the CB SAM were
tested. Figure 7 shows that the calibration curve for isolated IgG
is affected by a large SD (average RSD of 22.6% as compared to
average RSD of 8.9% for standard glycoprotein FET), which
might be explained by the presence of small components within
the serum depleted from highly abundant proteins. In forth-
coming studies, other methods will be applied to purify the IgG
fraction (i.e., using protein A/G columns). The LOD of 3.2 nM
calculated for isolated IgG was quite high due to the large SD of
the assays.
A gold surface patterned only by CB SAM was exposed to
IgG’s isolated from human serum with different dilutions to
probe nonspecific interactions. While only a negligible non-
specific signal was observed at dilutions 10 000× and 1000× the
isolated IgG’s, when the same concentration of IgG’s was applied
to the SNA-based biosensor, a good and reliable biospecific
response was obtained (Figure 8). Incubation of the IgG’s with
the CB SAM at a dilution of 100× resulted in a significant relative
response of 10.6% as compared to a biospecific relative response
of 63.8%. Accordingly, in subsequent experiments, isolated IgG’s
diluted 1000× were applied to glycoprofiling.
The final part of this study is the application of RCA- and SNA-
based biosensors to the glycoprofiling of IgG’s isolated from the
serum of healthy individuals and of those suffering from the RA
disease. In addition, a pool of samples from healthy individuals
was divided into two batches by the age of these individuals. The
results presented in Figure 9 show that the RCA lectin can hardly
distinguish between the IgG’s isolated from healthy individuals
and those suffering from RA (slope of 57.6± 2.0 vs 47.7± 1.6) at
different dilutions of IgG’s. Interestingly, the glycoprofiling of
IgG’s from young healthy individuals exhibited a larger signal
Figure 5. Charge-transfer resistance (RCT) of prepared surfaces after
each step of biosensor construction, for example, bare gold (Au), SAM
layer (+CB), SAM layer after SNA lectin immobilization (+SNA), and
the same surface after incubation with IgG stock solution (+IgG).
Figure 6. Calibration of EIS-based SNA lectin biosensor with two
different glycoproteins FET and ASF differing in amount of sialic acid
present on protein backbone. Calibration of SNA-based lectin
microarray with the same glycoproteins is provided to show differences
in sensitivity of analysis of glycoproteins by these two devices.
Figure 7. Calibration of EIS-based SNA lectin biosensor with either
whole human serum or IgG’s (antibodies) isolated from human serum
with various dilutions.
Figure 8. Investigation of protein adsorption resistant properties of
impedimetric SNA-based lectin biosensor developed on CB SAM-
modified gold surface. Nonspecific interaction of isolated IgG’s was
investigated by incubation of IgG’s with CB SAM-modified surface,
while a biospecific interaction was read by the EIS biosensor with SNA
lectin immobilized.
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(slope of 66.1 ± 2.2) than that of the other two types of IgG
samples (from RA patients and older healthy individuals).
The glycoprofiling of isolated IgG’s by the SNA-based
biosensor revealed larger differences among all three types of
samples in the present study as compared to the output obtained
by the RCA-based biosensor. While a moderate difference was
observed in the sialic acid content in the IgG’s isolated from the
serum of healthy older individuals and RA patients (slope of 10.5
± 1.4 vs 7.6 ± 1.6), the sialic acid on the IgG’s isolated from
young healthy individuals was much higher (slope of 36.4 ± 2.1)
than in the above two groups. In the most recent studies, it is
suggested that altered glycosylation might be age-related,
because glycan synthesis is influenced by the activity of two
different types of enzymes, that is, anabolic (glycosyltransferases)
and catabolic (exoglycosidases) enzymes. Age-driven changes in
the enzymatic activities of these two types of glycan-processing
enzymes thus result in an altered glycan synthesis.18,56,57 The
present results indicate that age-related changes in the glycan
profile should be taken into account to make glycoprofiling more
reliable for future diagnostics of various diseases.
IgG’s from all three types of human serum samples were also
glycoprofiled with SNA lectin in a microarray analysis. The
results showed that the EIS-based biosensor was capable of
providing reliable data, because validation of the biosensor by a
widely applied lectin microarray method was in good agreement
with R2 = 0.990 (Figure 10). The large error bars shown in Figure
10 are due to the analysis of several samples with each of the three
categories (RA, healthy older, healthy young) naturally differing
in the level of IgG and glycosylation.
Extensive recent strategies aimed at discovering novel
biomarkers have revealed that to have just a single biomarker
for a particular disease is proving quite elusive and that, for the
sensitive and specific diagnosis of different diseases, a panel of
biomarkers is required.58 As well as the frequent application of
several genetic and protein biomarkers, it is proposed that
glycoprofiling will be an important biomarker for inclusion in the
panel of biomarkers for future disease diagnostics.
4. CONCLUSIONS
The study investigated the preparation of a biointerface for an
easy, reproducible, robust, and sensitive impedimetric detection
of two carbohydrate residues (galactose and sialic acid) present
on the IgG molecules isolated from the human sera of healthy
individuals and patients with RA. Because the biological signal for
the assay derives from an affinity biorecognition event, it is
extremely important to adequately block nonspecific protein
adsorption on the surface. For this purpose, a new CB derivative
was synthesized, because zwitterionic materials are known to
offer good properties for resisting nonspecific protein binding.
By a simple chemical modification of gold electrode surfaces by
SAMs composed of a newly synthesized thiol (CB), it was
possible to prepare a highly sensitive impedimetric lectin-based
electrochemical assay. In addition, the lectin-based biosensors
were applied to the analysis of real human samples (IgG’s
isolated from human sera with glycans still attached to the Fc
fragment of IgG), and the SNA-based biosensor was able to
distinguish between patients suffering from RA and healthy
individuals. Furthermore, the study also revealed that the
desialylation and degalactosylation of human IgG’s might be an
age-related process,59 which should be taken into account for
these kinds of analyses in future works. To enhance the
robustness of glycoprofiling by the impedimetric lectin biosensor
based on CB, a more efficient blocking of the interface is needed,
which can result in a decreased LOD with increased specificity of
analysis. The analysis of one sample can be made considerably
less time-consuming by integration of the electrodes into an array
format of analysis. Furthermore, improved purification of the
antibodies from human serum is needed for overall enhancement
of IgG glycoprofiling.
Figure 9. Analysis of isolated IgG’s with different dilutions with RCA-based lectin biosensor (A) or SNA-based lectin biosensor (B) to detect changes in
content of galactose or sialic acid, respectively, within glycan structures.
Figure 10. Validation of glycoprofiling of IgG’s isolated from human
serum performed by EIS-based SNA lectin biosensor (x-axis) with
extensively used fluorescent SNA-based microarray (y-axis).
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(13) Baker, J. L.; Çelik, E.; DeLisa, M. P. Expanding the
glycoengineering toolbox: the rise of bacterial N-linked protein
glycosylation. Trends Biotechnol. 2013, 31, 313−323.
(14) Beck, A.; Reichert, J. M. Marketing approval of mogamulizumab.
mAbs 2012, 4, 419−425.
(15) Lepenies, B.; Seeberger, P. H. Simply better glycoproteins. Nat.
Biotechnol. 2014, 32, 443−445.
(16) Alley, W. R.; Mann, B. F.; Novotny, M. V. High-sensitivity
analytical approaches for the structural characterization of glycoproteins.
Chem. Rev. 2013, 113, 2668−2732.
(17) Gilgunn, S.; Conroy, P. J.; Saldova, R.; Rudd, P. M.; O’Kennedy,
R. J. Aberrant PSA glycosylation−a sweet predictor of prostate cancer.
Nat. Rev. Urol. 2013, 10, 99−107.
(18) Dall’Olio, F.; Vanhooren, V.; Chen, C. C.; Slagboom, P. E.;
Wuhrer, M.; Franceschi, C. N-glycomic biomarkers of biological aging
and longevity: A link with inflammaging. Ageing Res. Rev. 2013, 12, 685−
698.
(19) Goulabchand, R.; Vincent, T.; Batteux, F.; Eliaou, J.-f.; Guilpain,
P. Impact of autoantibody glycosylation in autoimmune diseases.
Autoimmun. Rev. 2014, 13, 742−750.
(20) Albrecht, S.; Unwin, L.; Muniyappa, M.; Rudd, P. M.
Glycosylation as a marker for inflammatory arthritis. Cancer Biomarkers
2014, 14, 17−28.
(21) Zauner, G.; Selman, M. H. J.; Bondt, A.; Rombouts, Y.; Blank, D.;
Deelder, A. M.; Wuhrer, M. Glycoproteomic analysis of antibodies.Mol.
Cell. Proteomics 2013, 12, 856−865.
(22) Tang, H.; Hsueh, P.; Kletter, D.; Bern, M.; Haab, B. The detection
and discovery of glycan motifs in biological samples using lectins and
antibodies: New methods and opportunities. In Advances in Cancer
Research; Richard, R. D., Lauren, E. B., Eds.; Academic Press: New York,
2015; Vol. 126, Chapter 5, pp 167−202.
(23) Cecioni, S.; Imberty, A.; Vidal, S. Glycomimetics versus
multivalent glycoconjugates for the design of high affinity lectin ligands.
Chem. Rev. 2015, 115, 525−561.
(24) Geissner, A.; Anish, C.; Seeberger, P. H. Glycan arrays as tools for
infectious disease research. Curr. Opin. Chem. Biol. 2014, 18, 38−45.
(25) Solis, D.; Bovin, N. V.; Davis, A. P.; Jimenez-Barbero, J.; Romero,
A.; Roy, R.; Smetana, K., Jr.; Gabius, H. J. A guide into glycosciences:
How chemistry, biochemistry and biology cooperate to crack the sugar
code. Biochim. Biophys. Acta 2015, 1850, 186−235.
(26) Song, X.; Heimburg-Molinaro, J.; Cummings, R. D.; Smith, D. F.
Chemistry of natural glycan microarrays. Curr. Opin. Chem. Biol. 2014,
18, 70−77.
(27) Tkac, J.; Davis, J. J. Label-free field effect protein sensing.
Engineering the Bioelectronic Interface: Applications to Analyte Biosensing
and Protein Detection; The Royal Society of Chemistry: UK, 2009;
Chapter 7, pp 193−224.
(28) Klukova, L.; Bertok, T.; Kasak, P.; Tkac, J. Nanoscale-controlled
architecture for the development of ultrasensitive lectin biosensors
applicable in glycomics. Anal. Methods 2014, 6, 4922−4931.
(29) Loaiza, O. A.; Lamas-Ardisana, P. J.; Jubete, E.; Ochoteco, E.;
Loinaz, I.; Cabañero, G. n.; García, I.; Penadeś, S. Nanostructured
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Mosnaćěk, J.; Lukać,̌ J.; Rovensky,́ J.; Imrich, R.; Tkac, J. Glycoprofiling
as a novel tool in serological assays of systemic sclerosis: A comparative
study with three bioanalytical methods. Anal. Chim. Acta 2015, 853,
555−562.
(46) Abdelsalam, M. E.; Bartlett, P. N.; Kelf, T.; Baumberg, J. Wetting
of regularly structured gold surfaces. Langmuir 2005, 21, 1753−1757.
(47) Mattiuzzi, A.; Jabin, I.; Mangeney, C.; Roux, C.; Reinaud, O.;
Santos, L.; Bergamini, J.-F.; Hapiot, P.; Lagrost, C. Electrografting of
calix[4]arenediazonium salts to form versatile robust platforms for
spatially controlled surface functionalization. Nat. Commun. 2012, 3,
1130.
(48) Rodriguez Emmenegger, C.; Brynda, E.; Riedel, T.; Sedlakova, Z.;
Houska, M.; Alles, A. B. Interaction of blood plasma with antifouling
surfaces. Langmuir 2009, 25, 6328−6333.
(49) Abraham, S.; Unsworth, L. D. Multi-functional initiator and
poly(carboxybetaine methacrylamides) for building biocompatible
surfaces using “nitroxide mediated free radical polymerization”
strategies. J. Polym. Sci., Part A: Polym. Chem. 2011, 49, 1051−1060.
(50) Lin, W.-C.; Lee, S.-H.; Karakachian, M.; Yu, B.-Y.; Chen, Y.-Y.;
Lin, Y.-C.; Kuo, C.-H.; Shyue, J.-J. Tuning the surface potential of gold
substrates arbitrarily with self-assembled monolayers with mixed
functional groups. Phys. Chem. Chem. Phys. 2009, 11, 6199−6204.
(51) Lin, J.-H.; Chang, H.-Y.; Kao, W.-L.; Lin, K.-Y.; Liao, H.-Y.; You,
Y.-W.; Kuo, Y.-T.; Kuo, D.-Y.; Chu, K.-J.; Chu, Y.-H.; Shyue, J.-J. Effect
of surface potential on extracellular matrix protein adsorption. Langmuir
2014, 30, 10328−10335.
(52) Chang, H.-Y.; Huang, C.-C.; Lin, K.-Y.; Kao, W.-L.; Liao, H.-Y.;
You, Y.-W.; Lin, J.-H.; Kuo, Y.-T.; Kuo, D.-Y.; Shyue, J.-J. Effect of
surface potential on NIH3T3 cell adhesion and Proliferation. J. Phys.
Chem. C 2014, 118, 14464−14470.
(53) Zhang, S.; Jiang, K.; Zhang, Q.; Guo, K.; Liu, Y. Serum fucosylated
paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of
early hepatocellular carcinoma using ELISA Index. Glycoconjugate J.
2015, 1−7.
(54) Hong, Q.; Lebrilla, C. B.; Miyamoto, S.; Ruhaak, L. R. Absolute
quantitation of immunoglobulin G and its glycoforms using multiple
reaction monitoring. Anal. Chem. 2013, 85, 8585−8593.
(55) Ahmed, U.; Anwar, A.; Savage, R. S.; Costa, M. L.; Mackay, N.;
Filer, A.; Raza, K.; Watts, R. A.; Winyard, P. G.; Tarr, J.; Haigh, R. C.;
Thornalley, P. J.; Rabbani, N. Biomarkers of early stage osteoarthritis,
rheumatoid arthritis and musculoskeletal health. Sci. Rep. 2015, 5, 9259
DOI: 10.1038/srep09259.
(56) Pawelec, G.; Goldeck, D.; Derhovanessian, E. Inflammation,
ageing and chronic disease. Curr. Opin. Immunol. 2014, 29, 23−28.
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